25I vs AZN: Side-by-Side Comparison
Compare IMMUPHARMA PLC LS-01 (25I) and Astrazeneca plc (AZN) side by side: market cap EUR 14.35M vs USD 302.65B. Financials, growth and model signals on Bullrun.
| Metric | 25I | AZN |
|---|---|---|
| Company | IMMUPHARMA PLC LS-01 | Astrazeneca plc |
| Country / Exchange | United Kingdom · F | United Kingdom · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers-General |
| Market cap | EUR 14.35M | USD 302.65B |
| P/E ratio | — | 58.6 |
| Dividend yield | — | 1.63% |
| Valuation model | — | 29.8% overvalued |
| Revenue (latest FY) | EUR 0 | — |
| Revenue growth YoY | — | — |
| Net income | EUR -2.48M | — |
| Gross margin | — | — |
| Diluted EPS | -0.01 | — |